{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T06:45:34Z","timestamp":1758091534441,"version":"3.44.0"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In Rheumatoid Arthritis (RA), pulmonary involvement is one of the most\nfrequent extra-articular manifestations. Several studies have demonstrated an association between\nRA-related lung disease and the positivity of anti-cyclic citrullinated peptide (anti-CCP) antibodies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Our aim is to describe the frequency of pulmonary involvement in the RA population\nand investigate the association between anti-CCP antibodies and diverse lung compartment involvement in RA patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>An observational retrospective cross-sectional study was conducted, during which data\nwere collected from the medical records of the patients with RA who had been tested for anti-CCP\nantibodies and had thoracic high resolution computerized tomography (HRCT) evaluation from\nJanuary 2011 to March 2022. The univariate and multivariate analyses using logistic regression\nmodels was performed to calculate odds ratios (ORs) with 95% CIs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 390 patients with RA were included, the mean age of patients was 58.99 \u00b1\n12.44 years, with a predominance of females (85.9%). Two hundred and fifty-two (64.6%) patients were positive for anti-CCP antibodies. The frequency of RA-related lung diseases was\n14.4% (n=56). The different manifestations observed in the thoracic HRCT included Nodules\n(67.9%), Interstitial lung disease (ILD) (28.6%), bronchiectasis (25%), fibrosis (21.4%), obliterative bronchiolitis (7.1%), and pleuritis (1.8%). In univariate and multivariate analysis, pulmonary\ninvolvement was associated with positive anti-CCP antibodies with an odds ratio (OR) of 5.25\n(95% CI: 2.17-12.70, p &lt; 0.0001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The study demonstrated a positive association between anti-CCP antibodies and pulmonary involvement in RA and highlighted the importance of tight monitoring in RA patients\nwith positive anti-CCP for pulmonary complications.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115733971298865240812063200","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:13:35Z","timestamp":1726445615000},"page":"410-417","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["What is the Link between Lung Involvement and Anti-CCP Antibodies in Rheumatoid Arthritis: A Cross-sectional Study"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4740-2618","authenticated-orcid":true,"given":"Hind","family":"El-Kasmi","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire Hassan II, BP:1835 Atlas, F\u00e8s, Avenue Hassan II, Fes\n30050, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoufik","family":"Harzy","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire Hassan II, BP:1835 Atlas, F\u00e8s, Avenue Hassan II, Fes\n30050, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nessrine","family":"Akasbi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centre Hospitalier Universitaire Hassan II, BP:1835 Atlas, F\u00e8s, Avenue Hassan II, Fes\n30050, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"Bullock J.","year":"2018","unstructured":"Bullock J.; Rizvi S.A.A.; Saleh A.M.; Ahmed S.S.; Do D.P.; Ansari R.A.; Ahmed J.; Rheumatoid Arthritis: A brief overview of the treatment. Med Princ Pract  2018,27(6),501-507","journal-title":"Med Princ Pract"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","volume":"21","author":"Young A.","year":"2007","unstructured":"Young A.; Koduri G.; Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol  2007,21(5),907-927","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s40744-021-00362-4","volume":"8","author":"Khan T.","year":"2021","unstructured":"Khan T.; Jose R.J.; Renzoni E.A.; Mouyis M.; A closer look at the role of anti-CCP antibodies in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and bronchiectasis. Rheumatol Ther  2021,8(4),1463-1475","journal-title":"Rheumatol Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-2007-985664","volume":"28","author":"Gauhar U.","year":"2007","unstructured":"Gauhar U.; Gaffo A.; Alarc\u00f3n G.; Pulmonary manifestations of rheumatoid arthritis. Semin Respir Crit Care Med  2007,28(4),430-440","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","volume":"74","author":"Juge P.A.","year":"2022","unstructured":"Juge P.A.; Granger B.; Debray M.P.; Ebstein E.; Louis-Sidney F.; Kedra J.; Doyle T.J.; Borie R.; Constantin A.; Combe B.; Flipo R.M.; Mariette X.; Vittecoq O.; Saraux A.; Carvajal-Alegria G.; Sibilia J.; Berenbaum F.; Kannengiesser C.; Boileau C.; Sparks J.A.; Crestani B.; Fautrel B.; Dieud\u00e9 P.; A risk score to detect subclinical rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis Rheumatol  2022,74(11),1755-1765","journal-title":"Arthritis Rheumatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"Juge P.A.","year":"2018","unstructured":"Juge P.A.; Lee J.S.; Ebstein E.; Furukawa H.; Dobrinskikh E.; Gazal S.; Kannengiesser C.; Ottaviani S.; Oka S.; Tohma S.; Tsuchiya N.; Rojas-Serrano J.; Gonz\u00e1lez-P\u00e9rez M.I.; Mej\u00eda M.; Buend\u00eda-Rold\u00e1n I.; Falf\u00e1n-Valencia R.; Ambrocio-Ortiz E.; Manali E.; Papiris S.A.; Karageorgas T.; Boumpas D.; Antoniou K.; van Moorsel C.H.M.; van der Vis J.; de Man Y.A.; Grutters J.C.; Wang Y.; Borie R.; Wemeau-Stervinou L.; Wallaert B.; Flipo R.M.; Nunes H.; Valeyre D.; Saidenberg-Kermanac\u2019h N.; Boissier M.C.; Marchand-Adam S.; Frazier A.; Richette P.; Allanore Y.; Sibilia J.; Dromer C.; Richez C.; Schaeverbeke T.; Liot\u00e9 H.; Thabut G.; Nathan N.; Amselem S.; Soubrier M.; Cottin V.; Cl\u00e9ment A.; Deane K.; Walts A.D.; Fingerlin T.; Fischer A.; Ryu J.H.; Matteson E.L.; Niewold T.B.; Assayag D.; Gross A.; Wolters P.; Schwarz M.I.; Holers M.; Solomon J.J.; Doyle T.; Rosas I.O.; Blauwendraat C.; Nalls M.A.; Debray M.P.; Boileau C.; Crestani B.; Schwartz D.A.; Dieud\u00e9 P.; MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med  2018,379(23),2209-2219","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10067-019-04846-1","volume":"39","author":"Li L.","year":"2020","unstructured":"Li L.; Liu R.; Zhang Y.; Zhou J.; Li Y.; Xu Y.; Gao S.; Zheng Y.; A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol  2020,39(5),1457-1470","journal-title":"Clin Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"0660","DOI":"10.1186\/s12890-018-0660-2","volume":"18","author":"Choi WI","year":"2018","unstructured":"Choi WI; Dauti S; Kim HJ; Park SH; Park JS; Lee CW; Risk factors for interstitial lung disease: A 9-year Nationwide population-based study. BMC Pulmonary Med  2018,18(96),0660","journal-title":"BMC Pulmonary Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12891-021-04985-0","volume":"23","author":"Oka S","year":"2022","unstructured":"Oka S; Higuchi T; Furukawa H; Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. BMC Musculoskelet Disord  2022,23,46","journal-title":"BMC Musculoskelet Disord"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/rheumatology\/keu195","volume":"53","author":"Perry E.","year":"2014","unstructured":"Perry E.; Kelly C.; Eggleton P.; De Soyza A.; Hutchinson D.; The lung in ACPA-positive rheumatoid arthritis: An initiating site of injury? Rheumatology (Oxford)  2014,53(11),1940-1950","journal-title":"Rheumatology (Oxford)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/annrheumdis-2013-203947","volume":"74","author":"Haj Hensvold A.","year":"2015","unstructured":"Haj Hensvold A.; Magnusson P.K.E.; Joshua V.; Hansson M.; Israelsson L.; Ferreira R.; Jakobsson P.J.; Holmdahl R.; Hammarstr\u00f6m L.; Malmstr\u00f6m V.; Askling J.; Klareskog L.; Catrina A.I.; Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: An epidemiological investigation in twins. Ann Rheum Dis  2015,74(2),375-380","journal-title":"Ann Rheum Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e0286191","DOI":"10.1371\/journal.pone.0286191","volume":"18","author":"Zhang M","year":"2023","unstructured":"Zhang M; Yin J; Zhang X; Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. PLoS One  2023,18(6),e0286191","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"Arnett F.C.","year":"1988","unstructured":"Arnett F.C.; Edworthy S.M.; Bloch D.A.; Mcshane D.J.; Fries J.F.; Cooper N.S.; Healey L.A.; Kaplan S.R.; Liang M.H.; Luthra H.S.; Medsger T.A.; Mitchell D.M.; Neustadt D.H.; Pinals R.S.; Schaller J.G.; Sharp J.T.; Wilder R.L.; Hunder G.G.; The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum  1988,31(3),315-324","journal-title":"Arthritis Rheum"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"Aletaha D.","year":"2010","unstructured":"Aletaha D.; Neogi T.; Silman A.J.; Funovits J.; Felson D.T.; Bingham C.O.; Birnbaum N.S.; Burmester G.R.; Bykerk V.P.; Cohen M.D.; Combe B.; Costenbader K.H.; Dougados M.; Emery P.; Ferraccioli G.; Hazes J.M.W.; Hobbs K.; Huizinga T.W.J.; Kavanaugh A.; Kay J.; Kvien T.K.; Laing T.; Mease P.; M\u00e9nard H.A.; Moreland L.W.; Naden R.L.; Pincus T.; Smolen J.S.; Stanislawska-Biernat E.; Symmons D.; Tak P.P.; Upchurch K.S.; Vencovsk\u00fd J.; Wolfe F.; Hawker G.; 2010 rheumatoid arthritis classification criteria: An american college of rheumatology\/european league against rheumatism collaborative initiative. Arthritis Rheum  2010,62(9),2569-2581","journal-title":"Arthritis Rheum"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"Prevoo M.L.L.","year":"1995","unstructured":"Prevoo M.L.L.; Van\u2019T Hof M.A.; Kuper H.H.; Van Leeuwen M.A.; Van De Putte L.B.A.; Van Riel P.L.C.M.; Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum  1995,38(1),44-48","journal-title":"Arthritis Rheum"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","volume":"58","author":"Duarte A.C.","year":"2019","unstructured":"Duarte A.C.; Porter J.C.; Leandro M.J.; The lung in a cohort of rheumatoid arthritis patients\u2014an overview of different types of involvement and treatment. Rheumatology (Oxford)  2019,58(11),2031-2038","journal-title":"Rheumatology (Oxford)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"S991","DOI":"10.55519\/JAMC-04-S4-9714","volume":"34","author":"Dahani A","year":"2022","unstructured":"Dahani A; Aamer N; Seerani NL; Karim MT; Khan F; Arain SR; Pulmonary manifestations in patients with rheumatoid arthritis visiting tertiary care hospital. J Ayub Med Coll Abbottabad  2022,34(Suppl 1),S991-S994","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","volume":"25","author":"Bilgici A.","year":"2005","unstructured":"Bilgici A.; Ulusoy H.; Kuru O.; \u00c7elenk \u00c7.; \u00dcnsal M.; Danac\u0131 M.; Pulmonary involvement in rheumatoid arthritis. Rheumatol Int  2005,25(6),429-435","journal-title":"Rheumatol Int"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","volume":"6","author":"Huang S.","year":"2020","unstructured":"Huang S.; Kronzer V.L.; Dellaripa P.F.; Deane K.D.; Bolster M.B.; Nagaraja V.; Khanna D.; Doyle T.J.; Sparks J.A.; Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol  2020,6(4),337-353","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/rheumatology\/ker258","volume":"50","author":"Bergstr\u00f6m U.","year":"2011","unstructured":"Bergstr\u00f6m U.; Jacobsson L.T.H.; Nilsson J.A.; Berglund G.; Turesson C.; Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford)  2011,50(11),2005-2013","journal-title":"Rheumatology (Oxford)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MD.0b013e318289ce01","volume":"92","author":"Richman N.C.","year":"2013","unstructured":"Richman N.C.; Yazdany J.; Graf J.; Chernitskiy V.; Imboden J.B.; Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine (Baltimore)  2013,92(2),92-97","journal-title":"Medicine (Baltimore)"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e17088","DOI":"10.1097\/MD.0000000000017088","volume":"98","author":"Salaffi F.","year":"2019","unstructured":"Salaffi F.; Carotti M.; Di Carlo M.; Tardella M.; Giovagnoni A.; High- resolution computed tomography of the lung in patients with rheumatoid arthritis. Medicine (Baltimore)  2019,98(38),e17088","journal-title":"Medicine (Baltimore)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/406927","volume":"2013","author":"Chen J.","year":"2013","unstructured":"Chen J.; Shi Y.; Wang X.; Huang H.; Ascherman D.; Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol  2013,2013,1-5","journal-title":"Clin Dev Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","volume":"73","author":"Giles J.T.","year":"2014","unstructured":"Giles J.T.; Danoff S.K.; Sokolove J.; Wagner C.A.; Winchester R.; Pappas D.A.; Siegelman S.; Connors G.; Robinson W.H.; Bathon J.M.; Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis  2014,73(8),1487-1494","journal-title":"Ann Rheum Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e92449","DOI":"10.1371\/journal.pone.0092449","volume":"9","author":"Yin Y","year":"2014","unstructured":"Yin Y; Liang D; Zhao L; Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis. PLoS One  2014,9(4),e92449","journal-title":"PLoS One"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","volume":"106","author":"Fischer A.","year":"2012","unstructured":"Fischer A.; Solomon J.J.; du Bois R.M.; Deane K.D.; Olson A.L.; Fernandez-Perez E.R.; Huie T.J.; Stevens A.D.; Gill M.B.; Rabinovitch A.M.; Lynch D.A.; Burns D.A.; Pineiro I.S.; Groshong S.D.; Duarte Achcar R.D.; Brown K.K.; Martin R.J.; Swigris J.J.; Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med  2012,106(7),1040-1047","journal-title":"Respir Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rmed.2019.06.016","volume":"154","author":"Katsumata M.","year":"2019","unstructured":"Katsumata M.; Hozumi H.; Yasui H.; Suzuki Y.; Kono M.; Karayama M.; Furuhashi K.; Enomoto N.; Fujisawa T.; Inui N.; Nakamura Y.; Suda T.; Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias. Respir Med  2019,154,102-108","journal-title":"Respir Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e040465","DOI":"10.1136\/bmjopen-2020-040465","volume":"1","author":"Kamiya H","year":"2021","unstructured":"Kamiya H; Panlaqui OM; Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. BMJ Open  2021,1(3),e040465","journal-title":"BMJ Open"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/rheumatology\/kex520","volume":"57","author":"Alunno A.","year":"2018","unstructured":"Alunno A.; Bistoni O.; Pratesi F.; La Paglia G.M.C.; Puxeddu I.; Migliorini P.; Gerli R.; Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis. Rheumatology (Oxford)  2018,57(5),850-855","journal-title":"Rheumatology (Oxford)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2019.01.001","volume":"200","author":"Liu Y.","year":"2019","unstructured":"Liu Y.; Liu C.; Li L.; Zhang F.; Li Y.; Zhang S.; High levels of antibodies to citrullinated \u03b1-enolase peptide-1 (CEP-1) identify erosions and interstitial lung disease (ILD) in a Chinese rheumatoid arthritis cohort. Clin Immunol  2019,200,10-15","journal-title":"Clin Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/art.39974","volume":"69","author":"Liao K.P.","year":"2017","unstructured":"Liao K.P.; Sparks J.A.; Hejblum B.P.; Kuo I.H.; Cui J.; Lahey L.J.; Cagan A.; Gainer V.S.; Liu W.; Cai T.T.; Sokolove J.; Cai T.; Phenome-wide association study of autoantibodies to citrullinated and noncitrullinated epitopes in rheumatoid arthritis. Arthritis Rheumatol  2017,69(4),742-749","journal-title":"Arthritis Rheumatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.40900","volume":"71","author":"England B.R.","year":"2019","unstructured":"England B.R.; Duryee M.J.; Roul P.; Mahajan T.D.; Singh N.; Poole J.A.; Ascherman D.P.; Caplan L.; Demoruelle M.K.; Deane K.D.; Klassen L.W.; Thiele G.M.; Mikuls T.R.; Malondialdehyde\u2013acetaldehyde adducts and antibody responses in rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis Rheumatol  2019,71(9),1483-1493","journal-title":"Arthritis Rheumatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.37881","volume":"65","author":"Harlow L.","year":"2013","unstructured":"Harlow L.; Rosas I.O.; Gochuico B.R.; Mikuls T.R.; Dellaripa P.F.; Oddis C.V.; Ascherman D.P.; Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum  2013,65(4),869-879","journal-title":"Arthritis Rheum"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S2665-9913(22)00380-0","volume":"5","author":"Kronzer V.L.","year":"2023","unstructured":"Kronzer V.L.; Hayashi K.; Yoshida K.; Davis J.M.; McDermott G.C.; Huang W.; Dellaripa P.F.; Cui J.; Feathers V.; Gill R.R.; Hatabu H.; Nishino M.; Blaustein R.; Crowson C.S.; Robinson W.H.; Sokolove J.; Liao K.P.; Weinblatt M.E.; Shadick N.A.; Doyle T.J.; Sparks J.A.; Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case\u2013control study. Lancet Rheumatol  2023,5(2),e77-e87","journal-title":"Lancet Rheumatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e001278","DOI":"10.1136\/rmdopen-2020-001278","volume":"6","author":"Joshua V.","year":"2020","unstructured":"Joshua V.; Hensvold A.H.; Reynisdottir G.; Hansson M.; Cornillet M.; Nogueira L.; Serre G.; Nyren S.; Karimi R.; Eklund A.; Sk\u00f6ld M.; Grunewald J.; Chatzidionysiou K.; Catrina A.; Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis. RMD Open  2020,6(2),e001278","journal-title":"RMD Open"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1007\/s10067-021-05808-2","volume":"40","author":"Xie S.","year":"2021","unstructured":"Xie S.; Li S.; Chen B.; Zhu Q.; Xu L.; Li F.; Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis\u2013related interstitial lung disease: A meta-analysis. Clin Rheumatol  2021,40(11),4533-4543","journal-title":"Clin Rheumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/s10165-010-0280-z","volume":"20","author":"Shidara K.","year":"2010","unstructured":"Shidara K.; Hoshi D.; Inoue E.; Yamada T.; Nakajima A.; Taniguchi A.; Hara M.; Momohara S.; Kamatani N.; Yamanaka H.; Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Mod Rheumatol  2010,20(3),280-286","journal-title":"Mod Rheumatol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.reumae.2019.05.006","volume":"17","author":"Paulin F.","year":"2021","unstructured":"Paulin F.; Doyle T.J.; Mercado J.F.; Fassola L.; Fern\u00e1ndez M.; Caro F.; Alberti M.L.; Esp\u00edndola M.E.C.; Buschiazzo E.; Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis. Reumatolog\u00eda Cl\u00ednica (English Edition)  2021,17(4),207-211","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e20220145","DOI":"10.36416\/1806-3756\/e20220145","volume":"48","author":"Severo C.R.","year":"2022","unstructured":"Severo C.R.; Chomiski C.; Valle M.B.D.; Escuissato D.L.; Paiva E.D.S.; Storrer K.M.; Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease. J Bras Pneumol  2022,48(6),e20220145","journal-title":"J Bras Pneumol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","volume":"9","author":"Kiely P","year":"2019","unstructured":"Kiely P; Busby AD; Nikiphorou E; Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open  2019,9(5),e028466","journal-title":"BMJ Open"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"h1269","DOI":"10.1136\/bmj.h1269","volume":"350","author":"Conway R","year":"2015","unstructured":"Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ; Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: Systematic literature review and meta-analysis of randomised controlled trials. BMJ  2015,350(5),h1269","journal-title":"BMJ"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.reumae.2021.12.003","volume":"19","author":"Narv\u00e1ez J.","year":"2023","unstructured":"Narv\u00e1ez J.; Aburto M.; Seoane-Mato D.; Bonilla G.; Acosta O.; Candelas G.; Cano-Jim\u00e9nez E.; Castellv\u00ed I.; Gonz\u00e1lez-Ruiz J.M.; Corominas H.; L\u00f3pez-Mu\u00f1iz B.; Mart\u00edn-L\u00f3pez M.; Robles-P\u00e9rez A.; Mena-V\u00e1zquez N.; Rodr\u00edguez-Portal J.A.; Ortiz A.M.; Sabater-Abad C.; Castrej\u00f3n I.; dos Santos R.; Garrote-Corral S.; Maese J.; Silva-Fern\u00e1ndez L.; Casta\u00f1eda S.; Valenzuela C.; Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatolog\u00eda Cl\u00ednica (English Edition)  2023,19(2),74-81","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971298865240812063200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234001\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971298865240812063200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:57:51Z","timestamp":1758005871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234001\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733971298865240812063200","relation":{},"ISSN":["1573-3971"],"issn-type":[{"type":"print","value":"1573-3971"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}